Lomedeucitinib, CAS 2328068-29-5

Product Description: Lomedeucitinib (BMS-986322) is act by targeting receptor tyrosine protein kinase (TYK2). Lomedeucitinib can be used for the research of plaque psoriasis[1].

Applications: COVID-19-immunoregulation

Formula: C18H17D3N6O4S

References: [1]Lomedeucitinib by Bristol-Myers Squibb for Plaque Psoriasis (Psoriasis Vulgaris): Likelihood of Approval.

CAS Number: 2328068-29-5

Molecular Weight: 419.47

Compound Purity: 99.75

Research Area: Inflammation/Immunology

Solubility: DMSO : 100 mg/mL (ultrasonic)

Target: Isotope-Labeled Compounds

• SKU: MEXHY-160144S-50
• Manufacturer: MedChemExpress
• Manufacturer SKU: HY-160144S-50
• Package Unit: 50 mg
• Quantity Unit: STK